VIP Supporting Member
- Sep 7, 2013
- Reaction score
- Columbus, GA USA
With AstraZeneca's vaccine trial still on pause in US, questions abound about study participants' mysterious illnesses
As US health authorities consider whether to allow AstraZeneca to resume the clinical trial of its coronavirus vaccine, crucial questions remain about neurological illnesses suffered by study participants who received injections of the experimental vaccine.